Since the recall, FDA has issued a general wanning on all dialysiscenters and is more acutely conscious of monitoring bicarbonate in dialysis patients in order to avoid the possibility of alkalosis by lessening possibility of any damage.
As a result of the recall, the FDA has issued a general warning to all dialysis centers to be more acutely conscious of monitoring bicarbonate levels in dialysis patients in order to minimize the possibility of alkalosis.